Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 15, 2020

SELL
$454.43 - $535.6 $266,295 - $313,861
-586 Closed
0 $0
Q2 2020

Jul 15, 2020

SELL
$334.87 - $493.06 $77,020 - $113,403
-230 Reduced 28.19%
586 $265,000
Q1 2020

Apr 17, 2020

BUY
$320.01 - $409.07 $39,681 - $50,724
124 Added 17.92%
816 $286,000
Q4 2019

Jan 15, 2020

SELL
$319.73 - $374.2 $6,714 - $7,858
-21 Reduced 2.95%
692 $256,000
Q3 2019

Oct 18, 2019

SELL
$304.55 - $345.24 $310,031 - $351,454
-1,018 Reduced 58.81%
713 $237,000
Q2 2019

Jul 11, 2019

BUY
$286.93 - $312.59 $3,156 - $3,438
11 Added 0.64%
1,731 $541,000
Q1 2019

Apr 12, 2019

BUY
$224.3 - $317.41 $106,318 - $150,452
474 Added 38.04%
1,720 $526,000
Q3 2018

Oct 18, 2018

BUY
$289.28 - $326.15 $360,442 - $406,382
1,246 New
1,246 $390,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.69B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.